NCT07704125

Brief Summary

This randomized controlled trial compares two postoperative voice behavior protocols in patients undergoing microlaryngeal surgery (phonosurgery) for benign vocal fold lesions such as polyps, cysts, and Reinke's edema. After surgery, patients often need to rest their voice while the vocal folds heal. Traditionally, patients are advised to observe absolute voice rest (complete silence) for several days. However, complete silence can be difficult to maintain and may cause psychological and social burden. The purpose of this study is to find out whether a five-day period of hypofunctional (soft, low-effort) whispering is as safe and effective as five days of absolute voice rest after phonosurgery. Patients were randomly assigned to one of two groups: absolute voice rest or hypofunctional whispering, for the first five days after surgery. From day six onward, both groups received the same standardized voice therapy delivered by a speech-language pathologist. Patients were evaluated before surgery and again at one month and three months after surgery. The main measure was the change in the Voice Handicap Index-30 (VHI-30), a patient-reported questionnaire about the impact of voice problems on daily life. Additional measures included voice-related quality of life, acoustic voice analysis, aerodynamic measurements, perceptual voice ratings, and videolaryngostroboscopic examination of the vocal folds. The study also assessed protocol compliance, quality of life, and patient satisfaction during the five-day protocol period

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 20, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2026

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 8, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 15, 2026

Completed
Last Updated

July 15, 2026

Status Verified

July 1, 2026

Enrollment Period

1.1 years

First QC Date

July 8, 2026

Last Update Submit

July 13, 2026

Conditions

Keywords

phonosurgerymicrolaryngeal surgeryvoice resthypofunctional whisperingvoice therapy

Outcome Measures

Primary Outcomes (1)

  • Change in Voice Handicap Index-30 (VHI-30) total score

    The Voice Handicap Index-30 (VHI-30) is a 30-item patient-reported questionnaire assessing the physical, functional, and emotional impact of voice disorders. Total score ranges from 0 to 120, with higher scores indicating greater voice-related handicap. The primary outcome was the change in VHI-30 total score from baseline to postoperative month 3. The established minimal clinically important difference (MCID) of 18 points was used as a reference.

    Baseline (preoperative), postoperative month 1, and postoperative month 3

Secondary Outcomes (9)

  • Change in Acoustic Voice Quality Index (AVQI)

    Baseline (preoperative), postoperative month 1, and postoperative month 3

  • Change in Acoustic Voice Quality Index (AVQI)

    Baseline (preoperative), postoperative month 1, and postoperative month 3

  • Change in Maximum Phonation Time (MPT)

    Baseline (preoperative), postoperative month 1, and postoperative month 3

  • Change in s/z ratio

    Baseline (preoperative), postoperative month 1, and postoperative month 3

  • Change in Auditory-Perceptual Voice Quality Assessed by the CAPE-V Protocol

    Baseline (preoperative), postoperative month 1, and postoperative month 3

  • +4 more secondary outcomes

Study Arms (2)

Absolute Voice Rest

ACTIVE COMPARATOR

Patients observed absolute voice rest (complete silence) for the first five postoperative days. From postoperative day six, they received a standardized voice therapy protocol delivered by a speech-language pathologist.

Behavioral: Absolute Voice Rest

Hypofunctional Whispering

EXPERIMENTAL

Patients used a hypofunctional whispering protocol (soft, low-effort whispering) for the first five postoperative days. From postoperative day six, they received the same standardized voice therapy protocol delivered by a speech-language pathologist.

Behavioral: Hypofunctional Whispering

Interventions

Complete voice rest (total silence) for five days after phonosurgery, followed by standardized voice therapy from day six.

Absolute Voice Rest

Soft, low-effort (hypofunctional) whispering for five days after phonosurgery, followed by standardized voice therapy from day six.

Hypofunctional Whispering

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Diagnosis of a benign vocal fold lesion (vocal fold polyp, cyst, or Reinke's edema)
  • Scheduled for microlaryngeal (phonosurgery) surgery under general anesthesia
  • Able to complete voice assessments and comply with the assigned postoperative voice behavior protocol
  • Provided written informed consent

You may not qualify if:

  • Malignant or premalignant vocal fold lesions
  • Previous laryngeal surgery or radiotherapy to the head and neck
  • Neurological voice disorders (e.g., vocal fold paralysis, spasmodic dysphonia)
  • Significant psychiatric or cognitive impairment preventing protocol compliance
  • Active smoking without cessation in Reinke's edema cases where required (if applicable)
  • Inability or unwillingness to attend follow-up assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University School of Medicine, Department of Otorhinolaryngology - Head and Neck Surgery

Istanbul, Istanbul, 34854, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Dysphonia

Condition Hierarchy (Ancestors)

Voice DisordersLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Fellow, Department of Otorhinolaryngology, Marmara University

Study Record Dates

First Submitted

July 8, 2026

First Posted

July 15, 2026

Study Start

February 20, 2025

Primary Completion

April 15, 2026

Study Completion

May 2, 2026

Last Updated

July 15, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations